TEM
The filing that makes traders squint
Tempus AI’s data chief just showed up in a Form 4 with a sale of 41,095 shares at a weighted average price of $49.61, putting the total haul at roughly $2.0 million. Not exactly pocket change, even by biotech-tech crossover standards.
Why investors care
Insider sales don’t always mean doom — executives sell for all kinds of boring adult reasons. But they do get extra attention when the company is already in the spotlight, especially after a segment reportedly grew 28% last quarter. If you’re holding TEM, the question is simple: is this a normal trim, or a little “thanks for the gains” moment?
The market’s favorite overreaction machine
A Form 4 can become a Rorschach test for investors pretty fast:
- Bulls say the sale may just reflect diversification, taxes, or a pre-set trading plan.
- Bears hear “top person is heading for the exit” and start doom-scrolling.
- Everyone else remembers that markets love to turn one filing into a full-blown soap opera.
Big picture: the filing is worth watching, but it’s one datapoint — not a verdict. The real stock story still comes down to whether Tempus can keep turning that segment growth into something more durable than a flashy quarterly headline.